Aveanna Healthcare (AVAH) Bank of America Home Care Conference summary
Event summary combining transcript, slides, and related documents.
Bank of America Home Care Conference summary
9 Dec, 2025Strategic vision and business model
Focused on scaling a diversified national platform, serving over 80,000 patients across 38 states with pediatric, adult, and geriatric home care services.
Recent acquisition of ThriveSkill Pediatrics expanded pediatric services into Kansas and New Mexico and increased density in five other states.
Maintains a diversified payer mix, with no single payer contributing more than 10% of revenue and 93 preferred payer agreements across business segments.
Strategic plan for 2025 centers on enhancing government and payer partnerships, cost efficiencies, business modernization, capital management, and employee engagement.
Long-term organic growth target is 5%-7%, with upside from value-based agreements and strategic tuck-in acquisitions.
Financial performance and outlook
Updated 2025 guidance: revenue expected to exceed $2.375 billion and Adjusted EBITDA above $300 million.
Q3 2025 marked the 11th consecutive quarter of beating and raising guidance.
Q3 revenue grew 22.2% year-over-year to $622 million, with EBITDA up 67.5% to $80.1 million.
Strong liquidity position with nearly $480 million available, including $146 million in cash and undrawn revolver.
Deleveraged by three full turns in 2023, with net leverage at 4.6x and a goal to be below 4x.
Segment performance and growth drivers
Private Duty Services (PDS) is the largest segment, representing 82% of revenue, with current organic growth in the high single digits.
Medical Solutions, 8% of revenue, is undergoing modernization, with growth expected to return to 8%-10% after Q1 2025.
Home Health and Hospice, 10% of revenue, is experiencing double-digit organic growth, expected to normalize to 5%-7% long term.
Preferred payer strategy has driven PDS managed care volumes from under 10% to nearly 60% in three years, with a target of mid-60s% in 2026 and potential to reach 80%+ in 2-3 years.
Value-based agreements and state reimbursement rate wins support growth and alignment with payer partners.
Latest events from Aveanna Healthcare
- Q2 revenue up 7% to $505M, adjusted EBITDA up 27%, guidance raised despite lower net income.AVAH
Q2 20242 Feb 2026 - Strategic transformation and rate wins drive growth, staffing, and margin expansion in 2024.AVAH
Healthcare Services Conference1 Feb 2026 - Accelerating growth via preferred payer strategy, targeting $200M EBITDA by 2026.AVAH
Jefferies Global Healthcare Conference1 Feb 2026 - 2025 guidance raised as transformation and Q3 results drive scalable, value-based growth.AVAH
44th Annual J.P. Morgan Healthcare Conference16 Jan 2026 - Q3 revenue up 6.5%, adjusted EBITDA rose 32.2%, and guidance was raised for 2024.AVAH
Q3 202416 Jan 2026 - Strategic transformation and efficiency drive growth, margin expansion, and strong cash flow.AVAH
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Strong 2024 revenue and margin gains, with 2025 guidance signaling further growth.AVAH
Q4 202424 Dec 2025 - Registering $400M in securities and 54M+ shares for resale, targeting home care growth.AVAH
Registration Filing16 Dec 2025 - Shelf registration allows ongoing securities offerings with strong board protections.AVAH
Registration Filing16 Dec 2025